iVAC 2L-pVAD

INTRODUCTION

iVAC 2L is a short term, fully percutaneous, 17Fr transfemoral LVAD that effectively generates blood flow up to 2 L/min. By actively unloading the LV, the iVAC 2L provides critical haemodynamic support during high-risk revascularization procedures, in cases of acute myocardial infarction and in cardiogenic shock. 
 

iVAC 2L is intended for use in patients with impaired LV function which requires LV MCS for up to 24 hours.

The general product features are: 

• Trans-aortic short-term LV Assist Device
• Percutaneous insertion
• Actively ejects left ventricular blood into the ascending aorta
• to 1.5 L/min (max. observed 2.0 L/min)6output to support the native heart
• Counter-pulsation system that creates additional pulsatility during diastole
• Driven by a conventional IABP console
• Non-significant hemolysis, fHb <10 μmol/L

Advantages:  

• Natural pulsatile support
• Fast and easy implementation
• Fully percutaneous approach
• Highly flexible catheter
• Cost effectiveness: iVAC 2L has a universally adaptable design that fully integrates with a standard IABP console

Key feature 

• “Synchronized flow” found in the iVAC 2L system creates additional pulsatility in the systemic vasculature, potentially improving peripheral perfusion.
• iVAC 2L may also optimize coronary blood flow.
• It increases oxygen delivery to the myocardium while sparing it from the additional burden of pumping blood against increased aortic impedance.